An advisory panel for the US Food and Drug Administration has recommended Johnson & Johnson’s single-dose FDA Vaccines and Related Biological Products Advisory Committee unanimously voted Friday afternoon to approve the vaccine.vaccine be given the green light by the FDA. The
The next step will be emergency approval from the FDA itself.
In early February, a week after announcing that its single-dose 66% effective overall in preventing COVID-19 in a global clinical trial, Johnson & Johnson submitted an application .was
It would be the third vaccine on the US market, following the FDA granting emergency use authorization for theand coronavirus vaccines in December, with vaccinations beginning just days later. Those vaccines are said to be 95% and 94% effective, respectively. Unlike the Pfizer and Moderna vaccines, .
Earlier this month, President Joe Biden announced that the US is buying enough doses ofin the country by the end of July — though this doesn’t mean everyone will be vaccinated by then.
“We’ve now purchased enough vaccine supply to vaccinate all Americans,” Biden said. Actually administering the vaccines to all Americans because vaccinations are managed at a state and local level.
Here’s, and here’s how to in your state.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.